Fundz
Researching ImmuneBridge?

Unlock the full ImmuneBridge story — free for 7 days, no credit card

Start a free Fundz Strategic trial: get everything on ImmuneBridge — investors, amounts, verified contacts — plus thousands more executive moves and a daily AI lead briefing built around your ICP. No credit card.

Everything on ImmuneBridge

Investors, amounts, the people behind it — and verified contacts.

Thousands more like it

Search every executive moves and more — filtered to your market.

AI leads for your ICP

A daily briefing of companies matching exactly who you sell to.

Use your work email — it’s how we set up your trial.

No credit card Full Strategic access for 7 days No commitment

Immune Bridge Promotes Dr. Nina Horowitz To CEO and Appoints Dr. Rui Tostoes As Chief Technology Officer

PRIVATEMar 24, 2026•3 months ago

Position

Chief Technology Officer

Company

ImmuneBridge

Rui Tostoes
San FranciscoBiotechnology

Description

ImmuneBridge has announced the promotion of Dr. Nina Horowitz to CEO, previously serving as the Chief Scientific Officer. Alongside this, Dr

Company Information

Company

ImmuneBridge

Location

2122 BRYANT ST

San Francisco, California, United States

About

ImmuneBridge is developing allogeneic immunotherapies for cancer. Our core technology drives the expansion of cord blood derived immune stem cells and establishes a novel, flexible, consistent and abundant cellular source for immunotherapies. We are currently pursuing natural killer cell products for hematological malignancies. Next we will use the unique advantages of our cellular source to tackle solid tumors.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for ImmuneBridge's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.